The Internet and the mail proved to be good aids in tracing chlamydia among young men. The results of an acclaimed project at Umeå University in Sweden are now being published in the September issue of the journal Eurosurveillance. With this method, 39 percent (396 of 1,016 interviewees), which is the highest published participation rate ever in a chlamydia screening of young men.
The project, being run by the researching general practitioner Daniel Novak together with his thesis director Roger Karlsson and Monica Jonsson at the Unit for General Medicine, covered all 22-year-old men in Umeå during the year 2002. In order to increase the rate of participation, attempts were made to make the taking of samples as little embarrassing, as anonymous, and as attractive as possible. Everyone received an envelope at home including an information sheet, a questionnaire, and a personally coded plastic capsule. Participation was voluntary, and only one researcher had access to the names behind the codes. Those men who wished to be tested submitted a urine sample in the coded capsule and sent it in to the laboratory. The samples were tested there for chlamydia, and the results were entered into a database. Participants could then see for themselves what their results were by entering their codes on a special Web page at the County Council. If their urine samples proved to contain chlamydia bacteria, they were urged to make contact for free treatment. The Internet page also contained detailed information about chlamydia and other sexually transferred diseases.
Four men of the 396 who sent in samples tested positive, which means a rate of prevalence among the group of 1.1 percent. This is a low figure, which indicates that the study reached men outside the risk group that seek out a test on their own.
Hans Fällman | alfa
Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University
Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
23.02.2017 | Physics and Astronomy
23.02.2017 | Earth Sciences
23.02.2017 | Life Sciences